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Abstract
Background: Retrospective analysis of effectiveness, technical problems, and complications of 
transvenous extraction of leads with the free endings migrated to the cardiovascular system (CVS). 
Methods: A 5-year-old database of transvenous lead extraction (TLE) procedures comprising 
906 patients with 1563 leads being removed was analyzed. TLE procedures of leads migrated 
in the CVS were compared with TLE procedures of leads with their proximal ends accessible 
in the pacemaker/implantable cardioverter-defi brillator (PM/ICD) pocket.
Results: In our material, the phenomenon of leads migration occurred in 5% of patients refer-
red for TLE and affected most frequently unipolar and atrial leads. The presence of migrating 
leads was associated with local venous occlusion in 64% of patients. Removal of migrating 
leads required other techniques than extraction of leads with their proximal ends accessible in 
the PM/ICD pocket. More than 95% of migrating leads were extracted transvenously, but pro-
cedures were signifi cantly longer. The presence of other leads made extraction of migrated leads 
even more complicated. Effectiveness and complication rates for removal of migrated leads and 
leads accessible in the PM/ICD pocket were similar.
Conclusions: We postulate that every lead migrating in the CVS should be considered for 
TLE. However, this extraction is technically more diffi cult and challenging than extraction of 
leads accessible in the PM/ICD pocket. (Cardiol J 2013; 20, 2: 161–169)
Key words: pacing complication, broken leads, extraction of migrating leads, 
venous occlusion
Introduction
There is a growing number of patients with 
abandoned endocardial leads. The decision to aban-
don inactive lead is made in case of pacing and/or 
sensing abnormalities, or changing and upgrading 
the pacing system. An abandoned, cut short, and not 
suffi ciently fi xed lead creates the risk of migration 
into the cardiovascular system (CVS) [1]. Active 
endocardial leads also may migrate to the CVS 
after their breakage. This may occur as a result of 
crush syndrome in case of an unfavorable position 
of a lead and the clavicle [2]. There also is a risk of 
lead fracture and later breakage at the site of liga-
ture tightening on the lead at the venous entrance. 
The migration of the proximal lead end (PLE) to 
the subclavian, anonymous vein, or superior vena 
cava creates loops, which in turn move through the 
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tricuspid valve to the right ventricle (RV), provo-
king tricuspid valve dysfunction and ventricular 
arrhythmias [1].
Sometimes, the free PLE drops in the right 
heart cavities or pulmonary artery, causing pulmo-
nary embolism [1]. Practically, every lead, the free 
ending of which is dropped in the CVS becomes 
a potential source of the above-mentioned consequ-
ences and is class 1 (lead with ending in CVS, which 
may pose an immediate threat to the patient if left 
in place, life threatening arrhythmias secondary to 
retained lead or lead fragment) or class 2b indica-
tion (lead which may pose a potential future threat 
to the patient if left in place) according to the latest 
guidelines of the Heart Rhythm Society (HRS) [3].
A number of centers have described their 
experience in transvenous lead extraction (TLE), 
presenting encouraging results of low percentage 
of complications [4–6]. There are no descriptions 
of TLE procedures with free PLE migrated to the 
CVS, based on a larger population of patients with 
such a problem, except a few case reports [4, 7–10].
The aim of our study was to analyze the effec-
tiveness, technical problems, and complications of 
TLE with PLE migrated to the CVS. An additional 
goal was to analyze after-effects and symptoms of 
long dwell times of PLE in the CVS and to present 
our original techniques of TLE with PLE in the CVS.
Methods
A retrospective analysis of a 5 year-old databa-
se of TLE procedures comprising 906 patients with 
1563 leads being extracted was carried out. The 
main database inclusion criterion was the dwell time 
of leads in the CVS. For pacemaker (PM) leads, it 
was > 12 months, and for implantable cardioverter-
-defi brillator (ICD) leads, > 6 months. Another 
inclusion criterion with shorter dwell times was 
the need to use additional tools, not provided with 
the lead by the manufacturer, because of ineffective 
simple traction. TLE procedures of leads with PLE 
migrated to the CVS were compared with TLE 
procedures of leads with their proximal endings 
accessible in the PM/ICD pocket. For this reason, 
patients were enrolled in two arms of the study. 
One arm — Group A comprised patients with at least 
one lead, the PLE of which migrated to the CVS, and 
the other arm — Group B included the remaining 
patients. The following parameters were compared: 
(1). Patients’ age and gender; (2) Indications for ex-
traction in three groups: lead-dependent infective 
endocarditis (LDIE), local pocket infection, other 
noninfectious indications; (3) Number of existing 
and removed leads per patient; (4) Extracted lead 
dwell times; (5) Technique of TLE; (6) Procedure 
effectiveness understood as complete removal of 
all planned leads; (7) A technical complication was 
regarded as an appearance of a new technical prob-
lem during TLE, which had to be solved, prolonging 
the duration of procedures. The following technical 
complications were encountered: subclavian vein 
entry block (metal sheath or another technique 
was used), lead fragmentation (extraction in two 
parts), lead breakage (lead fragment extraction), 
loss of liberated distal lead fragment (additional 
removal of lead fragment from the CVS), strong 
lead-to-lead adhesion (simultaneous liberation 
with two dilators), functional lead dislodgement, 
and Byrd dilator fracture (only replacement); 
(8) Procedure complications (minor and major) 
and radiological success defi ned according to the 
HRS guidelines [3]. Based on the data, we analyzed 
probable reasons for PLE migration to the CVS. 
The site and mechanism of lead breakage can be 
diagnosed only when, during reimplantation, the 
proximal fragment of the lead connected to the 
device in the poket is removed. Additionally, we 
analyzed the fi nal migration site of the PLE as well 
as the incidence of total or partial venous occlusion 
in the PLE site in the subgroup of patients with 
migrating leads. For the latter reason, prior to 
TLE, we performed venography with intravenous 
contrast medium in the cubital fossa on the side 
of the PM/ICD pocket in those patients (Fig. 1).
TLE procedures were performed af ter 
patient’s written informed consent form for the 
operation and also consent use his medical records 
anonymously for research purposes.
Description of lead extraction methods
Leads accessible from the PM/ICD pocket 
were described before [11].
Procedure 1. TLE with ends migrated to the 
CVS when PLE was not strongly ingrown into the 
wall of the CVS (Fig. 2). Such leads were usually 
extracted via a femoral vein. The access to CVS was 
obtained using Cook Femoral Work Station® (FWS) 
or Medtronic Attain CS set® or Biotronik Scout CS 
set® designed for left ventricular lead implantation. 
A “pigtail” catheter was introduced additionally to 
the use of the above-mentioned sets and wound 
around the lead under removal, maneuvering the 
liberated PLE to the vena cava inferior. At this 
moment, extraction with the femoral approach was 
continued most frequently. The PLE was grasped 
with a Basket Dotter® or lasso catheter, and sim-
ple traction or countertraction (internal sheath of 
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Figure 1. Intraoperative fluoroscopy during venography visualizing veins with the migrating leads; A. Mild occlusion 
of the left subclavian vein; B. Significant occlusion of the left subclavian vein — collaterals.
Figure 2. Intraoperative fluoroscopy during removal of the migrating lead (procedure 1); A. The pigtail catheter wo-
und around the lead in the right atrium; B. Freeing the proximal end of the lead; C. Lead proximal end in vena cava 
inferior with pigtail wound around it; D. Dotters basket grasping the proximal tip in the vena cava inferior; E. Dotters 
basket closed, enabling firm traction of the lead via the femoral approach; F. Extracted migrating lead on the table 
with Dotters basket.
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FWS) was attempted. These maneuvers sometimes 
were suffi cient to liberate the lead with its tip off 
the adhesions in the heart walls. If the distal part of 
the lead very strongly adhered to the surrounding 
tissue scar, there was a need for separation using 
extra-long polypropylene Byrd dilators or manually 
modifi ed external or internal FWS sheaths. The 
manual modifi cation was carried out by cutting the 
edges of the catheters diagonally, which broadened 
their function from countertraction to rotation-
-cutting as well. Cutting off lead adhesions with the 
help of manually modifi ed FWS is more effective 
and safer than applying only countertraction force 
which can tear CVS walls. However, manufactures 
of FWS have not anticipated the need of cutting of 
migrating lead adhesions. For that reason manual 
modifi cation of the FWS ending during such pro-
cedures is necessary.
Procedure 2. TLE with ends migrated to the 
CVS when PLE was strongly ingrown into the wall 
of the CVS (Fig. 3). In the case of strong adhesion 
of both lead ends to the CVS, the authors employed 
their original method, that is, the extracted lead 
with strongly ingrown endings was looped by the 
strong angiocardiographic guidewire introduced via 
the pigtail catheter, and the distal part of the angio-
cardiographic guidewire was grasped by a Basket 
Dotter® or lasso catheter (both tools were similarly 
useful). Either mentioned tool was introduced via 
the same femoral vein but via a separate approach 
and inside a larger sheath (FWS, Medtronic Attain 
CS set® or Biotronik Scout CS set®). Manual traction 
applied to the guidewire and simultaneously to the ba-
sket/lasso catheter liberated one of the extracted lead 
endings (usually, the proximal one but not always). 
The liberated extracted lead end was grasped using 
Basket Dotter® or lasso catheter, whereas rotation 
of the catheter (obliquely cut FWS sheath or Byrd 
dilator) was used to liberate the remaining ending. If 
the distal ingrown lead tip was located in the RV apex 
and the angulation in the tricuspid valve region was 
too sharp, we used the superior approach (recaptured 
subclavian approach or jugular approach) to intercept 
the previously liberated lead ending with another 
Basket Dotter® or lasso catheter.
Sporadically, an approach from the internal jugu-
lar or subclavian vein opposite to the PM/ICD pocket 
was used. We developed our own technique, which 
permits to draw Byrd dilators over these tools [8].
Ingrowing of the migrating PLE into the 
CVS walls was not determined before choosing 
the extraction approach. We used a stepped-up 
approach: fi rst trying with a pigtail catheter to free 
the proximal (or distal end) — procedure 1, and if 
the pigtail did not suffi ce, then we snared the lead 
to free one or the other end with traction — pro-
cedure 2. After one end of the lead was freed, we 
fi rst tried to extract the lead with traction, or if it 
was not successful, by inserting a sheath over the 
lead to free it from scar tissue.
If the access technique was modifi ed during 
the procedure, it was referred to as a complex pro-
Figure 3. Intraoperative fluoroscopy during freeing the two adherent endings of the migrating lead (procedure 2); 
A. A strong angiocardiographic guidewire, inside the pigtail, passing through the lead loop in the right atrium; B. Distal 
part of the angiocardiographic guidewire grasped by a Dotter basket; C. Manual traction simultaneously applied to 
the two ends of the loop formed by the guidewire; D. Liberated distal lead tip; E. Dotters basket grasping the tip in 
the vena cava inferior; F. Dotters basket, pigtail catheter and extracted lead on the table.
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cedure. In the cases of infectious indications when 
all existing endocardial leads were removed, the 
procedures began from TLE of leads accessible in 
the pocket, whereas for noninfectious indications, 
only migrated or redundant leads were planned to 
be extracted. In the case when venous occlusion 
prevented the implanting of the new leads by subc-
lavian venipuncture, the patient had to undergo re-
moval of the lead accessible in the pocket to regain 
venous access from pocket site. The migrating lead 
was extracted at the same time.
All removal procedures were performed under 
light general anesthesia (propofol) in an operating 
room with cardiac surgery, anesthesiology backup, 
and monitoring of patients’ vital signs.
Statistical analysis
Statistical analysis was carried out using 
Statistica version 9.1 (Stat Soft). Minimum and 
maximum values, means, and standard deviations 
were calculated for continuous variables, whereas 
qualitative variables were presented as absolute 
and percentage quantities. The Shapiro-Wilk test 
for normality was used to analyze continuous 
outcome variables. Unpaired Student’s t-test was 
used to compare two quantitative variables, and 
when the data sets were skewed or scanty, a non-
-parametric Mann-Whitney U-test was performed. 
Pearson’s c2 test was used to compare qualitative 
variables, whereas Yates’s c2 test was used for 
small samples (less than 5 subjects). A p value 
< 0.05 was considered statistically signifi cant.
Results
Group A with the migrating PLE consisted of 
45 patients. Of the 45 removed migrating leads in 
these 45 patients, 40 leads with PLE accessible 
in the PM/ICD pocket were extracted. These 
45 patients made up 5% of the 906 patients. The 
remaining 861 patients served as the control group 
(B) with 1478 leads having been extracted.
Characteristics of migrating extracted 
leads. The phenomenon of PLE migration into the 
CVS seems to be most typical of atrial, unipolar 
leads (Table 1).
Final migration site of the PLE of 45 mi -
grating leads. The PLE was anchored in the 
subclavian vein, 19 cases; in the innominate vein 
(12), in the right atrium (4), in the pulmonary 
artery (3), in the vena cava superior (2), in the 
jugular vein (2); in the right ventricle (2), and in 
the hepatic vein (1).
Probable reasons of lead migration to the 
CVS. In 24 patients, in the previously functional 
lead, after its breakage, the PLE slid into the CVS, 
which manifested in 16 patients as sudden loss of 
pacing/sensing. The patients received new leads 
in other centers.
The proximal end of the lead connected to the 
device in the pocket was removed in our center in 
8 cases. In this way, in 5 patients, crush syndrome 
was detected, and in another 3 patients, complete 
lead breakage was caused by too tight ligature on 
the distal edge of the anchoring sleeve.
In another 21 patients, the migrating leads 
were previously abandoned and inactive. The 
probable reason of migration was abandoned PLE 
ligature failure. However, in 5 patients, the lead 
was attempted to be extracted by manual traction in 
other centers, and if it was ineffective, the lead was 
cut in the venous entrance region without ligature.
Time of PLE adhesion to CVS walls is diffi cult 
to specify even in the case of 16 patients with sud-
Table 1. Migrating lead models; comparison with the control group.
Group A Group B P
Number of leads (only migrating 
leads in group A)
45 1478 –
Location of the tip of the lead A 27/45
60.00%
655/1478
44.32%
0.0371
V 18/45
40.00%
823/1478
55.68%
Lead model (polarity) BP 26/45 
57.78%
1332/1478
90.12%
< 0.00001
UP 19/45
42.22%
146/1478
9.88%
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den loss of pacing/sensing and 5 patients with in-
tentional consent for PLE migration to CVS lumen.
Main reasons for referring the patient 
with migrating leads for TLE. Eight patients 
had LDIE, 7 had local pocket infection, and as many 
as 30 (66.7%) presented different noninfectious 
indications: migrating leads recognized as leads 
which may pose a potential future threat to the 
patient if left in place (27 patients), intolerance 
of VVI mode of pacing after atrial lead breakage 
(8 patients), another lead failure (7 patients), venous 
occlusion precluding additional lead implantation 
(12 patients), and symptoms of superior vena cava 
syndrome (3 patients). Most patients were refer-
red when elective PM/ICD unit replacement was 
indicated. There were not signifi cant differences 
in indications for TLE in both groups of patients 
(Table 2).
Migrating lead extraction methods. The 
complexity of PM/ICD systems and lead dwell 
times were signifi cantly higher in patients with 
migrating leads (Table 2). The presence of other 
leads hampered the extraction of the migrating 
leads. Therefore, in 15 patients with infectious 
indications for TLE, the leads accessible from the 
PM/ICD pocket were removed fi rst. In the rema-
ining 30 patients with noninfectious indications, 
active leads were left in place. However, the active 
lead was dislodged accidentally in 3 patients, and 
for this reason, it had to be reimplanted at a later 
stage of the procedure. In one patient 2 year-old, 
still functional leads had to be extracted to enable 
the removal of the migrating lead. In 12 patients 
with a needed implantation of new leads by regai-
ning access to the heart, this procedure was made 
after migrating lead extraction. If we analyze TLE 
of migrating leads only, it is clear that the femoral 
approach was used most frequently (in 66.7%) 
and combined (usually femoral plus recaptured 
subclavian or jugular) approach were used in 33.3% 
patients. In 1 case, after unsuccessful TLE combi-
ned approach, migrating lead was extracted with 
cardio surgery. In patients from Group A, except 
45 migrating leads, we extracted 40 leads more, 
with accessible proximal ending in the PM/ICD 
pocket, which explains why the venous entry side 
was also used in this group of patients (Table 3). 
In the B group, the subclavian approach was used 
for TLE as standard (84.1%); complex approach 
was used only in case of technical complications 
(15.9%; Table 3).
Remarks on technical aspects of migra-
ting lead extraction. Only in 12 among 45 (26.7%) 
patients, it was possible to use procedure 1. In the 
remaining 33 (73.3%) we used procedure 2. It is 
very interesting that the pulling of the extracted 
lead with the loop liberated fi rst the distal tip of 
the lead in 12 patients, which means that the PLE 
was more strongly ingrown in the CVS wall than 
the distal tip of the lead. It is even stranger if we 
consider the mean dwell time of migrating leads 
(more than 10 years). According to our experience 
Table 2. Demographic data, indications for transvenous lead extraction (TLE), complexity of the system 
measured by the number of leads in the heart and the number of extracted leads in a single patient.
Group A Group B P
Number of patients [%] 45/906 [5.0] 861/906 [95.0] –
Number of extracted leads 85 1478 –
Gender: males [%] 26/45 [57.8] 635/861 [73.7] 0.0187
Patients’ age [years] (SD) 12–88
64.7 (18.4)
5–94
64.7 (16.2)
0.6024
Number of leads in patient 
before TLE procedure (SD)
1–4
2.56 (0.87)
1–5
2.00 (0.83)
< 0.0001
Number of leads extracted 
in a single patient (SD)
1–4
2.02 (1.45)
1–6
1.73 (0.83)
0.0030
Mean dwell time of leads [months] (SD) 
(only for migrating leads in group A)
76–276
122.2 (62.8)
7–386
80.9 (60.2)
< 0.00001
Indications for TLE LDIE [%] 8/45 [17.8] 168/861 [19.5] 0.7744
Pocket infection [%] 7/45 [15.6] 237/861 [27.5] 0.0776
Non-infective indications [%] 30/45 [66.7] 456/861 [53.0] 0.0723
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Table 3. Mode of lead extraction and utilized approach.
Group A Group B P
Number of extracted leads 85 1478
Final approach for 
extraction of all 
leads
Simple traction [%] 6/85 [7.1] 181/1478 [0.5] 0.2071
Subclavian: venous entry 
side [%]
36/85 [42.3] 1243/1478 [84.1] < 0.00001
Femoral [%] 30/85 [35.3] 5/1478 [0.3] < 0.00001
Combined [%] 12/85 [14.1] 42/1478 [2.8] < 0.00001
Cardiosurgery [%] 1/85 [1.2] 7/1478 [0.5] 0.9187
the strength of broken PLE adhesion to CVS walls 
depends on whether there is metal wire sticking 
out of the polymer insulation, which increases the 
strength of adhesion. We have not noticed the con-
nection of the phenomenon of PLE strong adhesion 
either with multiple leads in the superior vena cava, 
or atrial leads. However, it must be noted that the 
number of strongly adhering PLE’s is still too small 
for statistical analysis. 
We encountered major technical problems during 
extraction in 6 patients when it was necessary to se-
parate the proximal end using cutting-rotation forces.
Thirty-three patients in whom the PLE was 
liberated fi rst, the intracardiac tip was liberated 
by traction of the grasped PLE in 13 subjects, 
whereas in the remaining 20 patients, it was ne-
cessary to separate the tip from the tissue scar in 
the atrium or the ventricle using extra-long Byrd 
dilators (9 patients) or obliquely cut sheath of FWS 
(11 patients).
In the whole group, fi rm grasping and pulling 
via a femoral approach resulted in lead extraction 
in 19 (42%) patients, whereas separation of adhe-
sions, using cutting-rotation forces, was required 
in 26 (58%) patients with migrating leads. Clinical 
success rate was very high and similar in both 
groups (more than 95%, Table 4).
The slightly lower radiological success of TLE 
without accessible PLEs was a result of 4 lead tips 
left in the heart wall, and one lead left for cardiac 
surgery. Technical complications were more fre-
quent in the migrating than in the control group 
(44.4% vs. 15.8%). It explains prolongation of the 
procedure by a mean of more than 1 h (Table 4). 
There were no signifi cant differences in procedural 
complication between groups.
PLE fi nal location and venous fl ow. Among 
patients with migrating leads, there was a high rate 
of total (26.7%) or partial (37.8%) occlusion of the 
vein in which the migrating PLEs were primarily 
located (Fig. 1, Table 5).
Discussion
In the present study of all patients selected for 
TLE, 45 (5%) subjects had migrating leads. The 
Table 4. Effectiveness and complications of transvenous lead extraction in the compared groups of 
patients.
Group A Group B P
No of procedures 45 861
Full clinical success 43/45 (95.6%) 850/861 (98.7%) 0.2720
Full radiological success 40/45 (88.9%) 816/861 (94.8%) 0.0920
Technical complications 20/45 (44.4%) 136/861 (15.8%) 0.00001
Procedure minor complications 1/45 (2.2%) 15/861 (1.7%) 0.7322
Procedure major complications 0/45 (0.0%) 9/861 (1.0%) 0.9349
Whole procedure duration [min] (SD) 65–370
169.2 (73.1)
30–420
109.5 (46.5)
< 0.00001
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number of patients with such leads varies from 
investigator to investigator. Bongiorni et al. [4] 
encountered 73 (3.5%) migrating leads among 2062 
leads. Bohm et al. [1] followed up 60 abandoned 
leads including 5 (8.3%) patients with migrating 
leads. None of them underwent TLE. In 2 cases 
with major complications, the leads were extracted 
surgically, and the remaining 3 patients received 
anticoagulant or antiaggregation therapy. Despite 
much more significant technical complications 
associated with removal of migrating leads, their 
fi nal effectiveness, at the level of above 88.9%, 
was comparable to the effectiveness of extracting 
leads with their proximal ends accessible in the 
PM/ICD pocket. Bongiorni et al. [4] reported 
a 100% effectiveness of migrating lead removal in 
16 (21.9%) cases as a result of traction via the 
femoral approach and in the remaining 57 (78.1%) 
after separation of adhesions via a jugular approach 
using polypropylene Byrd dilators. In their study, 
the extracted leads were younger: 69.3 vs. 80.9 
months regarding leads with their end accessible 
in the PM/ICD pocket and 122.2 months for mi-
grating leads in our material. The complication 
rate in the present study was equally low in both 
subgroups, that is, 2.2% for migrating leads and 
2.7% for the remaining ones. Bongiorni et al. [4] 
instead of separate complication rates for migrating 
lead removal via the femoral and jugular approach 
provided the collective rate of 4.7%. Their paper 
describes an original modifi cation of transvenous 
removal of leads accessible in the PM/ICD pocket 
(156 leads), that is, the leads, which were made to 
drop in the CVS and then extracted via the jugular 
approach [4]. These intentionally-made migrating 
leads had no chance to adhere to the cardiac walls 
as they were removed immediately. The difference 
between the migrating leads during surgical mani-
pulation and the leads left in place for some time is 
the degree of adhesion of the PLE to the CVS wall. 
In the present study, there were only migrating 
and ingrown leads. Extraction of migrating leads 
requires other techniques than of those with their 
PLE accessible in the PM/ICD pocket. In our study, 
the removal of migrating leads signifi cantly more 
often required modifi cation of the approach, being 
a challenge to the operators. Strength of adherence 
of PLE to CVS wall is probably a function of time. 
However, the moment of lead breakage and PLE 
migration to the CVS is often unnoticed. Case re-
ports confi rm the need for adjusting the techniques 
with modifi cation of instruments used for removal 
of migrating leads [7–10]. According to our expe-
rience the use of other devices (needle eye snare 
or bioptome) was less effective and was replaced 
by the techniques presented in the method section.
We noticed that the presence of leads with 
their proximal ends migrated to the venous system 
was associated with a high rate of vein occlusion 
(64%). This was not mentioned in other reports. 
Female sex predominance in the present study was 
probably accidental.
Conclusions
1.  Migrating non-functional leads with PLE in the 
CVS were observed in 5% of patients referred 
for TLE.
2.  Removal of migrating leads required other 
techniques than extraction of leads with their 
PLE accessible in the PM/ICD pocket.
3.  PLEs were strongly ingrown and adherent to the 
CVS wall in 33 (73.3%) cases of migrating leads.
4.  Migrating leads were associated with local 
venous occlusion.
Table 5. Condition of venous system in migrating proximal lead end region (vein occlusion degree).
Normal Partial 
occlusion
Total 
occlusion
P (normal venous 
vs. occlusion)
Normal venous system 16/45 
(35.5%)
0/45 
(0.0%)
0/45 
(0.0%)
< 0.00001
Vein  occlusion Subclavian vein 0/45 
(0.0%)
8/45 
(17.8%)
7/45 
(15.6%)
Anonymous vein 0/45 
(0.0%)
6/45 
(13.3%)
5/45 
(11.1%)
Superior vena cava 0/45 
(0.0%)
3/45 
(6.7%)
0/45 
(0.0%)
Total 16/45 
(35.5%)
17/45 
(37.8%)
12/45 
(26.7%)
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5.  Effectiveness and procedural complication 
rate for extraction of migrating leads and leads 
accessible in the PM/ICD pocket were similar.
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